Home › Mylan: Outperformed S&P 500 Since June, And Shows No Signs Of Slowing
 

Keywords :   


Mylan: Outperformed S&P 500 Since June, And Shows No Signs Of Slowing

2015-01-22 16:03:15| Biotech - Topix.net

Mylan has shown alpha returns over the past year, beating the S&P 500 by approximately 4% in the past four months. The outlook for the drug device combination products industry is expected to grow at a CAGR rate of 7.9% through to 2019.

Tags: of june shows signs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.10Hurricane Milton Forecast Discussion Number 18
09.10Hurricane Milton Public Advisory Number 18
09.10Hurricane Milton Wind Speed Probabilities Number 18
09.10Hurricane Milton Forecast Advisory Number 18
09.10Hurricane Leslie Graphics
09.10Hurricane Leslie Forecast Discussion Number 29
09.10Xaar announces Versatex Printbar integration with Jet iQ
09.10Hurricane Leslie Forecast Advisory Number 29
More »